|
15 Sep 2010 |
Immune Targeting Systems (ITS) Ltd. Announces First Patient Treated in Phase I Trial of Synthetic Universal Influenza Vaccine
|
|
14 Sep 2010 |
CytoGenix, Inc. Announces Positive Results from DNA Vaccine Study for Avian Flu
|
|
13 Sep 2010 |
Stealt Peptides Inc. Announces Clinical Phase I Results With Bendavia Demonstrating Safety And Tolerability With Highly Predictable Pharmacokinetics
|
|
13 Sep 2010 |
FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
|
|
13 Sep 2010 |
Inovio Pharmaceuticals Achieves Unprecedented T-Cell Immune Responses in Human Trial of DNA Vaccine for Cervical Dysplasia and Cancer Caused by HPV
|
|
13 Sep 2010 |
Novartis Phase III study shows meningococcal B vaccine candidate could be first to provide broad coverage against deadly disease
|
|
13 Sep 2010 |
Vical's TransVax(TM) CMV Vaccine Achieves Statistical Significance on Key Clinical Endpoints in Phase 2 Trial
|
|
10 Sep 2010 |
NanoBio to Present Clinical Data on its Nanoemulsion Adjuvanted Intranasal Flu Vaccine and Novel Anti-Acne Treatment at ICAAC 2010
|
|
10 Sep 2010 |
Advaxis Publishes Research on New Her2 Vaccine
|
|
08 Sep 2010 |
ImmunoCellular Therapeutics Announces Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma
|
|
08 Sep 2010 |
Medicago announces a single low dose of its H5 VLP Vaccine achieves 100% cross-protection in lethal challenge study in ferrets
|
|
08 Sep 2010 |
ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)
|
|
06 Sep 2010 |
Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan
|
|
03 Sep 2010 |
Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
|
|
01 Sep 2010 |
Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
|
|
30 Aug 2010 |
Two Thirds of Study Volunteers Respond to First-Ever "Re-Vaccination" of Vacc-4x, Bionor Pharma's Peptide-Based Therapeutic HIV-Vaccine
|
|
26 Aug 2010 |
The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development
|
|
26 Aug 2010 |
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra Vaccine to Infants and Toddlers
|
|
24 Aug 2010 |
GSK European Commission amends licence for Cervarix
|
|
18 Aug 2010 |
Advaxis Completes Dosing Vanguard Group in Phase II Cervical Dysplasia (CIN) Study
|
|
17 Aug 2010 |
MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
|
|
17 Aug 2010 |
BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine
|
|
17 Aug 2010 |
Memorandum of Understandings for UMN Pharma's Cell Culture Based Influenza Vaccine Programas in Japan
|
|
16 Aug 2010 |
Selecta Biosciences Receives $3 Million from NIH/NIDA to Develop Nicotine Vaccine for Smoking Cessation
|
|
12 Aug 2010 |
Novavax Reports Positive Results from Pre-Clinical Safety Study of Respiratory Syncytial Virus (RSV) Vaccine Candidate
|
